Cary A. Presant, MD, FACP, FASCO, is a hematologist and medical oncologist with the City of Hope Medical Group. He has been involved in laboratory and clinical investigations, and has served as director of cancer programs at Washington University School of Medicine, the Jewish Hospital of St. Louis and the City of Hope National Medical Center in Los Angeles, California. He is currently Professor of Clinical Medicine at the University of Southern California School of Medicine. Dr. Presant's current research is focused on predictive assays to increase survival, pharmacologic improvement of chemotherapy effectiveness by magnetic resonance spectroscopy, and the development of new therapeutic programs for cancer.
He is the author of more than 400 scientific articles and is a recognized expert in cancer treatment, cancer detection, chemotherapy, experimental tumor biology and pharmacology, liposomes for cancer diagnosis and therapy, magnetic resonance spectroscopy, measurement of quality of life in cancer patients, and quality care in oncology. Dr. Presant has authored Surviving American Medicine, and is a physician columnist and authors blogs for the national website "Medscape."
Dr. Presant is a past Director of the American Society of Clinical Oncology, and received the ASCO Statesman Award in 2007. He is a Past President of the Association of Community Cancer Centers. Additionally, Dr. Presant was honored as one of the "Best Doctors in America."
Because of his commitment to early diagnosis of cancer, Dr. Presant was appointed by Fran Drescher to the Board of Directors of her charitable organization Cancer Schmancer. From 2004 until 2007 Dr. Presant co-chaired the national Oncology Congress. Since 2008 Dr. Presant has also served as the Director of Medical Oncology for DiaTech Oncology to develop an effective chemotherapy sensitivity test for cancer patients.
Dr. Presant received his medical degree from the State University of New York at Buffalo, and completed postdoctoral training at Columbia University in New York City, the National Cancer Institute in Bethesda, Maryland, and Washington University School of Medicine in St. Louis, Missouri.
